BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7497797)

  • 21. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis.
    Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Ann Palliat Med; 2022 Oct; 11(10):3181-3192. PubMed ID: 36226644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
    Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020.
    Sun KY; Fan Y; Wang YX; Zhong YJ; Wang GF
    Semin Arthritis Rheum; 2021 Feb; 51(1):175-191. PubMed ID: 33383294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.
    Kang EH; Lee EB; Shin KC; Im CH; Chung DH; Han SK; Song YW
    Rheumatology (Oxford); 2005 Oct; 44(10):1282-6. PubMed ID: 15972351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
    Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
    Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases.
    Shen H; Xia L; Lu J
    Cytokine; 2012 Nov; 60(2):334-7. PubMed ID: 22863719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
    Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bibliometric analysis of the research status and trends in studies on polymyositis and dermatomyositis with interstitial lung disease from 2000 to 2022 using Web of Science.
    Ma XN; Feng W; Chen SL; Zhong XQ; Zheng XX; Lin CS; Xu Q
    Immun Inflamm Dis; 2024 Feb; 12(2):e1190. PubMed ID: 38376948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologics in polymyositis and dermatomyositis-associated interstitial lung disease.
    Sun Y; He Y; Liu Y; Shi G
    Curr Pharm Biotechnol; 2014; 15(6):521-4. PubMed ID: 25213360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
    PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis.
    Yamanaka Y; Baba T; Hagiwara E; Yanagawa N; Takemura T; Nagaoka S; Sakai F; Kuwano K; Ogura T
    Eur J Radiol; 2018 Oct; 107():26-32. PubMed ID: 30292269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive Association between
    Li L; Chen S; Wen X; Wang Q; Lv G; Li J; Yang F; Zhang F; Li Y
    Biomed Res Int; 2017; 2017():2905987. PubMed ID: 28470010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
    Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J
    Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis.
    Wang H; Lv J; He J; Wu W; Zhong Y; Cao S; Cai Y; Wang Q
    Autoimmun Rev; 2023 Aug; 22(8):103335. PubMed ID: 37164215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications.
    Zhang S; Shu X; Tian X; Chen F; Lu X; Wang G
    Clin Exp Immunol; 2014 Jul; 177(1):134-41. PubMed ID: 24611519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease.
    Ihn H; Asano Y; Kubo M; Yamane K; Jinnin M; Yazawa N; Fujimoto M; Tamaki K
    Rheumatology (Oxford); 2002 Nov; 41(11):1268-72. PubMed ID: 12421999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.